Statistics for Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2
Total visits
| views | |
|---|---|
| Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2 | 2 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:e5bc482d-8be8-4844-a468-1fd93949e16d | 31 |
| Clark2021LongTerm-CCBYNC.pdf | 10 |
| java.util.UUID:991e1784-4def-4bc0-bda9-3289c978454e | 9 |
| java.util.UUID:73a13293-9048-45a8-9698-a03680c8828d | 8 |
Top country views
| views | |
|---|---|
| United States | 2 |
Top city views
| views | |
|---|---|
| Franklin | 2 |